Hyperventilation syndrome in children with asthma.

Hyperventilation syndrome children hyperventilation test severe asthma

Journal

The Journal of asthma : official journal of the Association for the Care of Asthma
ISSN: 1532-4303
Titre abrégé: J Asthma
Pays: England
ID NLM: 8106454

Informations de publication

Date de publication:
Nov 2023
Historique:
pubmed: 24 4 2023
medline: 24 4 2023
entrez: 24 04 2023
Statut: ppublish

Résumé

Hyperventilation syndrome (HVS) may be associated with asthma. In the absence of a gold standard diagnosis for children, its impact on asthma has been rarely assessed. To assess the impact of HVS on the symptoms and lung function of children with asthma and determine the diagnostic value of the Nijmegen questionnaire in comparison to a hyperventilation test (HVT). Data from asthmatic children followed in the department of Pediatric Pulmonology of Necker Hospital and explored for HVS were retrospectively analyzed. HVS was diagnosed by a positive HVT. Asthma exacerbations, control and lung function were assessed in children with or without a positive HVT. The sensitivity and specificity of the Nijmegen questionnaire were determined relative to the positivity of a HVT. The Nijmegen questionnaire threshold was ≥23. Data from 112 asthmatic children, median age 13.9 years [11.6-16], were analyzed. Twenty-eight children (25%) had mild or moderate asthma and 84 (75%) severe asthma. The HVT was performed on 108 children and was negative for 34 (31.5%) and positive for 74 (68.5%). The number of asthma exacerbations in the past 12 months, Asthma Control Test (ACT) score, and lung function did not differ between children with a positive HVT and a negative HVT. The Nijmegen questionnaire was administered to 103 children. Its sensitivity was 56.3% and specificity 56.3%. The symptoms and lung function of adolescents with asthma are not affected by the presence of HVS. The sensitivity and specificity of the Nijmegen questionnaire are low.

Sections du résumé

BACKGROUND UNASSIGNED
Hyperventilation syndrome (HVS) may be associated with asthma. In the absence of a gold standard diagnosis for children, its impact on asthma has been rarely assessed.
OBJECTIVE UNASSIGNED
To assess the impact of HVS on the symptoms and lung function of children with asthma and determine the diagnostic value of the Nijmegen questionnaire in comparison to a hyperventilation test (HVT).
METHODS UNASSIGNED
Data from asthmatic children followed in the department of Pediatric Pulmonology of Necker Hospital and explored for HVS were retrospectively analyzed. HVS was diagnosed by a positive HVT. Asthma exacerbations, control and lung function were assessed in children with or without a positive HVT. The sensitivity and specificity of the Nijmegen questionnaire were determined relative to the positivity of a HVT. The Nijmegen questionnaire threshold was ≥23.
RESULTS UNASSIGNED
Data from 112 asthmatic children, median age 13.9 years [11.6-16], were analyzed. Twenty-eight children (25%) had mild or moderate asthma and 84 (75%) severe asthma. The HVT was performed on 108 children and was negative for 34 (31.5%) and positive for 74 (68.5%). The number of asthma exacerbations in the past 12 months, Asthma Control Test (ACT) score, and lung function did not differ between children with a positive HVT and a negative HVT. The Nijmegen questionnaire was administered to 103 children. Its sensitivity was 56.3% and specificity 56.3%.
CONCLUSION UNASSIGNED
The symptoms and lung function of adolescents with asthma are not affected by the presence of HVS. The sensitivity and specificity of the Nijmegen questionnaire are low.

Identifiants

pubmed: 37092722
doi: 10.1080/02770903.2023.2206903
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1987-1996

Auteurs

Manon Beauvais (M)

Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Rola Abou Taam (RA)

Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Antoine Neuraz (A)

Data Science Platform, INSERM UMR 1163, Université de Paris Cité, Imagine Institute, Paris, France.

Muriel Le Bourgeois (M)

Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Christophe Delacourt (C)

Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Hassan Faour (H)

Data Science Platform, INSERM UMR 1163, Université de Paris Cité, Imagine Institute, Paris, France.

Nicolas Garcelon (N)

Data Science Platform, INSERM UMR 1163, Université de Paris Cité, Imagine Institute, Paris, France.

Guillaume Lezmi (G)

Department of Pediatric Pneumology and Allergology, Necker-Enfants Malades Hospital, AP-HP, Université Paris Cité, Paris, France.

Classifications MeSH